CCDC68 Activators
Compounds that demonstrate a significant upregulation of the protein's activity would be selected for further investigation. These initial hits would then undergo a battery of secondary assays, which serve to confirm the compound's specific action on CCDC68 and to rule out nonspecific effects or assay artifacts that could lead to false positives. Upon establishing a subset of compounds as genuine activators of CCDC68, the focus would shift to understanding the interaction between these molecules and the protein at a molecular level. Techniques like X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy may be applied to determine the structural basis of the activation. These methods can reveal where and how the activators bind to the protein, shedding light on the conformational changes that correlate with increased activity.
Alongside structural studies, biophysical techniques such as isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) would be utilized to measure the thermodynamics and kinetics of binding, respectively. Such data contribute to the understanding of the strength and duration of the interaction between activators and CCDC68. Concurrently, chemists would engage in structure-activity relationship (SAR) studies, systematically modifying the chemical structure of the activators to refine their properties. This iterative process aims to enhance the potency, selectivity, and overall profile of the activators by examining the effects of each modification on the interaction with CCDC68. These combined efforts would provide a comprehensive picture of the nature and mechanism of activation of CCDC68 by the activator compounds.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). Activation of PKC has been shown to modulate various cellular processes, and by influencing these processes, PKC activation could indirectly enhance the functional activity of CCDC68 through pathways that CCDC68 is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium levels can activate calcium-dependent signaling pathways, potentially enhancing CCDC68 activity if CCDC68 is regulated by calcium-sensitive proteins or processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP and cGMP. By preventing the degradation of cAMP, IBMX can indirectly enhance CCDC68 activity through sustained PKA signaling, which could phosphorylate substrates related to CCDC68's function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt the mTOR signaling pathway. This pathway regulates several cellular processes, including protein synthesis and autophagy. Inhibition of mTOR might indirectly enhance CCDC68 activity by modulating cellular processes or stress responses in which CCDC68 might be involved. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an AMP analog that activates AMP-activated protein kinase (AMPK). Activation of AMPK can lead to various cellular responses including metabolic regulation. If CCDC68 function is linked to metabolic processes, AICAR could enhance CCDC68 activity by altering the metabolic state of the cell, which may indirectly influence CCDC68's role. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. The elevation of intracellular calcium can activate calcium-dependent signaling pathways, potentially enhancing CCDC68 activity if CCDC68 is influenced by calcium-mediated signaling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is a metabolite of vitamin A that regulates gene expression by activating nuclear retinoic acid receptors. If CCDC68 is modulated by retinoic acid-responsive elements or related signaling pathways, retinoic acid could enhance CCDC68 activity through genomic regulation. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc Pyrithione is a coordination complex of zinc that has been found to increase intracellular zinc levels. Zinc can act as a signaling molecule and influence various pathways, including those involving kinases and phosphatases. If CCDC68 activity is regulated by zinc-sensitive pathways, the increased levels of zinc could indirectly enhance CCDC68 function. | ||||||